Literature DB >> 10704948

Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects.

M Akil1, C L Edgar, J N Pierri, S Casali, D A Lewis.   

Abstract

BACKGROUND: We recently reported a laminar-specific reduction in the density of tyrosine hydroxylase (TH)-immunoreactive axons in the prefrontal cortex of subjects with schizophrenia. In this report, we extend these investigations to the entorhinal cortex (ERC), another candidate site of dysfunction in this disorder.
METHODS: Using immunocytochemical techniques and blind quantitative analyses, we determined the density of TH-immunoreactive axons in the rostral subdivision of the ERC from seven matched pairs of schizophrenic and control subjects.
RESULTS: The relative density of TH-labeled axons was significantly decreased by over 60% in layers 3 and 6, but not in layer 1, of the ERC in schizophrenic subjects. In contrast, in the prefrontal cortex of the same subjects, labeled axon density was significantly decreased by 62% only in layer 6. Furthermore, the length of TH-labeled axons did not differ between six matched pairs of nonschizophrenic psychiatric and control subjects in any layer of the ERC. Finally, the density of TH-labeled axons in the ERC of cynomolgus monkeys chronically treated with haloperidol was not reduced relative to control animals.
CONCLUSIONS: These findings reveal regional- and laminar-specific alterations in TH-immunoreactive axons that appear to be specific to the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704948     DOI: 10.1016/s0006-3223(99)00282-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  24 in total

1.  Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.

Authors:  Scott E Hemby; John Q Trojanowski; Stephen D Ginsberg
Journal:  J Comp Neurol       Date:  2003-02-03       Impact factor: 3.215

2.  Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.

Authors:  Lawrence S Kegeles; Mark Slifstein; Xiaoyan Xu; Nina Urban; Judy L Thompson; Tiffany Moadel; Jill M Harkavy-Friedman; Roberto Gil; Marc Laruelle; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2010-07-31       Impact factor: 13.382

3.  Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Rosalinda C Roberts; Miguel Melendez-Ferro; Emma Perez-Costas
Journal:  Brain Struct Funct       Date:  2014-10-01       Impact factor: 3.270

Review 4.  Presynaptic dopamine in schizophrenia.

Authors:  Nobumi Miyake; Judy Thompson; Mette Skinbjerg; Anissa Abi-Dargham
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

5.  Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque.

Authors:  Lynn D Selemon; Lei Wang; Mary Beth Nebel; John G Csernansky; Patricia S Goldman-Rakic; Pasko Rakic
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

Review 6.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

Review 7.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 8.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 9.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1.

Authors:  Hanna Jaaro-Peled; Akiko Hayashi-Takagi; Saurav Seshadri; Atsushi Kamiya; Nicholas J Brandon; Akira Sawa
Journal:  Trends Neurosci       Date:  2009-08-26       Impact factor: 13.837

Review 10.  Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Authors:  Jodi J Weinstein; Muhammad O Chohan; Mark Slifstein; Lawrence S Kegeles; Holly Moore; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2016-03-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.